INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 30, 2011 |
Director, EVP CSO President Regeneron Re
Trans History: 628
|
Director, EVP CSO President Regeneron Re | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 196,430 | -- | -- |
| Nov 23, 2011 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
| Nov 22, 2011 |
Director
Trans History: 320
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | -- |
| Nov 18, 2011 |
Director
Trans History: 111
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 25,000 |
| Nov 15, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Nov 14, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Oct 14, 2011 |
Director
Trans History: 381
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | -- | 5,000 |
| Oct 11, 2011 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 1,387 |
| Oct 10, 2011 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 9,372 | -- | -- |
| Oct 10, 2011 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 18,128 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.